Valentin Harter

Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective study

C. Charra-Brunaud, Valentin Harter, M. Delannes et al. · Radiotherapy and Oncology · 2012 · 366 citations

Cervical Cancer, Medical Imaging, Radiation Therapy +8

Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses

Christian Pfister, Gwénaëlle Gravis, Aude Fléchon et al. · European Urology · 2020 · 238 citations · Full text

Urology, Genitourinary Cancer, Chemotherapy Toxicity +7

SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicing

Raphaël Leman, Béatrice Parfait, Dominique Vidaud et al. · Human Mutation · 2022 · 84 citations · Full text

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study

Christian Pfister, Gwénaëlle Gravis, Aude Fléchon et al. · The Lancet Oncology · 2023 · 77 citations

Survival Endpoints, Surgical Oncology, Urology +7

Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families

Laurent Castéra, Valentin Harter, Etienne Müller et al. · Genetics in Medicine · 2018 · 71 citations · Full text

Functional Genomics, Cancer Epidemiology, Molecular Epidemiology +15